Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Compass Therapeutics (CMPX) Shares Issued (2023 - 2026)

Compass Therapeutics' Shares Issued history spans 4 years, with the latest figure at $3.9 million for Q1 2026.

  • On a quarterly basis, Shares Issued changed N/A to $3.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.1 million, a 899.81% increase, with the full-year FY2025 number at $1.3 million, down 92.96% from a year prior.
  • Shares Issued hit $3.9 million in Q1 2026 for Compass Therapeutics, up from -$136.7 million in the prior quarter.
  • Over the last five years, Shares Issued for CMPX hit a ceiling of $138.0 million in Q3 2025 and a floor of -$136.7 million in Q4 2025.
  • Historically, Shares Issued has averaged $3.3 million across 4 years, with a median of $3.1 million in 2023.
  • The widest YoY moves for Shares Issued: up 83.45% in 2024, down 83.45% in 2024.
  • Tracing CMPX's Shares Issued over 4 years: stood at $3.1 million in 2023, then crashed by 83.26% to $513000.0 in 2024, then plummeted by 26751.85% to -$136.7 million in 2025, then surged by 102.82% to $3.9 million in 2026.
  • Business Quant data shows Shares Issued for CMPX at $3.9 million in Q1 2026, -$136.7 million in Q4 2025, and $138.0 million in Q3 2025.